Insider Transactions in Q3 2024 at Harrow Health, Inc. (HROW)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
John P. Saharek CEO of ImprimisRx |
SELL
Payment of exercise price or tax liability
|
Direct |
45,140
-13.09%
|
$1,850,740
$41.37 P/Share
|
|
Sep 11
2024
|
John P. Saharek CEO of ImprimisRx |
BUY
Exercise of conversion of derivative security
|
Direct |
90,000
+20.7%
|
$630,000
$7.37 P/Share
|